Hitherto, there are limited studies on RAG1 focusing molecular phylogenetic analyses, evolutionary traits, and genetic variants in human populations.
To mimic complicated genomic variants in human diseases, such as multiple gene deletions or mutations, two or more small guide RNAs (sgRNAs) need to be introduced all together.
We compiled 751 genetic variants in human RAG1 gene using 1092 human genomes; where major stockholders of variant classes are 79% single nucleotide polymorphisms (SNPs), 12.2% somatic single nucleotide variants (somatic SNVs) and 6.8% deletion.
Previous genome-wide linkage and association studies have not found strong evidence for the contribution of common variants besides the APOE gene, suggesting the role of rare variants in human longevity.
Based on the sequences published in GenBank and Ensembl, we designed specific primers and detected by PCR three mRNA species in murine tissues and eight variants in human cells.
The abundance of infrequent non-synonymous variants in human populations has been difficult to explain in terms of adaptive shift.
On the other hand, the lack of reported natural replication-competent MLV variants in human population would make spontaneous complementation of replication-deficient vectors improbable.
However, our findings indicate that it would be prudent to screen these (as well as other) MPZ non-coding sequences for functional variants in human populations.
In this paper, we described the transcriptome-wide identification and characterization of cancer-specific and alternatively spliced variants in human cancer based on a global view of cancer-specific alternative splicing developed by subtractive transcriptome-wide analysis.
Temporal changes in the proportion of non-synonymous and RNA gene variants in human mtDNA were analyzed in 3057 sequences considering variation of coding region between positions 577 and 16023.
Using qPCR and quantitative multicolor flow cytometric analysis, we have measured the protein expression, splicing and transcript levels to prove the functionality of the rare T1D variants in human immune cell subsets.
